Risedronate Slows or Partly Reverses Cortical and Trabecular Microarchitectural Deterioration in Postmenopausal Women
Yohann Bala(The University of Melbourne), René Rizzoli, Angela M. Cheung(Westat (United States)), Ego Seeman(The University of Melbourne), J. Reeve(Nuffield Orthopaedic Centre), Dieter Felsenberg(Charité - Universitätsmedizin Berlin), Michel Laroche(Royal Bank of Canada), Thierry Thomas(Lyon 1 Université), Edward Morris(University of East Anglia), Roger Martin Zebaze Djoumessi(The University of Melbourne), Oliver Bock, José Zanchetta(Universidad del Salvador), Roland Chapurlat(Lyon 1 Université), Ali Ghasemzadeh(The University of Melbourne)
Cited by 41
Related Papers
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
|New England Journal of Medicine|2001|4.6k
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
|New England Journal of Medicine|2009|3.5k
Functional Disability 5 Years after Acute Respiratory Distress Syndrome
|New England Journal of Medicine|2011|2.8k
Romosozumab in Postmenopausal Women with Low Bone Mineral Density
|New England Journal of Medicine|2014|1.2k
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women
|Osteoporosis International|2007|1.2k